Suicidal Ideation Across the Lifespan Among Commercially Insured Outpatients: Retrospective Cohort Study.

Dena M Bravata^1,2, James M Hudson², Severin Kibby², Neha P Chaudhary^2,3, Taft Parsons Iii⁴, Nicole M Benson^2,5

¹Center for Primary Care and Outcomes Research, Stanford University, Palo Alto, CA, United States.

²TherapyMatch (dba Headway), New York, NY, United States.

³Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States.

⁴CVS/Aetna, Detroit, MI, United States.

⁵Harvard Medical School, McLean Hospital, 115 Mill St, Belmont, MA, 02478, United States, 1 617-855-2000.

PubMed DOI

Abstract

BACKGROUND: Suicide remains a leading cause of death in the United States and is on the rise. Limited evidence describes the current burden of suicidal ideation (SI) among commercially insured outpatients, a population that represents a large and rapidly expanding segment of those seeking care. OBJECTIVE: The objective of this study was to characterize the prevalence of SI among a national cohort…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.